Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00153803 · COMPLETED

Trial details

NCT number: NCT00153803
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Non-small Cell Lung Cancer NSCLC

Start date: 2005-05-01
Primary completion: 2014-04-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.